496 related articles for article (PubMed ID: 18493248)
1. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers R; Maurice P; Boutin JA; Delagrange P
Br J Pharmacol; 2008 Jul; 154(6):1182-95. PubMed ID: 18493248
[TBL] [Abstract][Full Text] [Related]
2. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization.
Levoye A; Dam J; Ayoub MA; Guillaume JL; Couturier C; Delagrange P; Jockers R
EMBO J; 2006 Jul; 25(13):3012-23. PubMed ID: 16778767
[TBL] [Abstract][Full Text] [Related]
3. Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.
Wu N; Carpino G; Ceci L; Baiocchi L; Francis H; Kennedy L; Zhou T; Chen L; Sato K; Kyritsi K; Meadows V; Ekser B; Franchitto A; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Hepatology; 2022 Apr; 75(4):797-813. PubMed ID: 34743371
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors.
Mailliet F; Audinot V; Malpaux B; Bonnaud A; Delagrange P; Migaud M; Barrett P; Viaud-Massuard MC; Lesieur D; Lefoulon F; Renard P; Boutin JA
Biochem Pharmacol; 2004 Feb; 67(4):667-77. PubMed ID: 14757166
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms.
Das A; Wallace G; Reiter RJ; Varma AK; Ray SK; Banik NL
J Pineal Res; 2013 Jan; 54(1):58-68. PubMed ID: 22823500
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).
Gautier C; Guenin SP; Riest-Fery I; Perry TJ; Legros C; Nosjean O; Simonneaux V; Grützner F; Boutin JA
PLoS One; 2018; 13(3):e0191904. PubMed ID: 29529033
[TBL] [Abstract][Full Text] [Related]
7. Distribution of melatonin receptors in murine pancreatic islets.
Nagorny CL; Sathanoori R; Voss U; Mulder H; Wierup N
J Pineal Res; 2011 May; 50(4):412-7. PubMed ID: 21355877
[TBL] [Abstract][Full Text] [Related]
8. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
[TBL] [Abstract][Full Text] [Related]
9. Melatonin receptor heterodimerization in a photoreceptor-like cell line endogenously expressing melatonin receptors.
Sánchez-Bretaño A; Suen TC; Baba K; DeBruyne J; Tosini G
Mol Vis; 2019; 25():791-799. PubMed ID: 31819341
[TBL] [Abstract][Full Text] [Related]
10. Melatonin MT
Chen M; Cecon E; Karamitri A; Gao W; Gerbier R; Ahmad R; Jockers R
J Pineal Res; 2020 May; 68(4):e12641. PubMed ID: 32080899
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function.
Oishi A; Cecon E; Jockers R
Int Rev Cell Mol Biol; 2018; 338():59-77. PubMed ID: 29699692
[TBL] [Abstract][Full Text] [Related]
12. Changes in melatonin receptor expression in a murine model of glaucoma.
Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Carracedo G; Pintor J
Mol Vis; 2020; 26():530-539. PubMed ID: 32818016
[TBL] [Abstract][Full Text] [Related]
13. Melatonin receptor structure and signaling.
Okamoto HH; Cecon E; Nureki O; Rivara S; Jockers R
J Pineal Res; 2024 Apr; 76(3):e12952. PubMed ID: 38587234
[TBL] [Abstract][Full Text] [Related]
14. A molecular and chemical perspective in defining melatonin receptor subtype selectivity.
Chan KH; Wong YH
Int J Mol Sci; 2013 Sep; 14(9):18385-406. PubMed ID: 24018885
[TBL] [Abstract][Full Text] [Related]
15. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.
Ayoub MA; Levoye A; Delagrange P; Jockers R
Mol Pharmacol; 2004 Aug; 66(2):312-21. PubMed ID: 15266022
[TBL] [Abstract][Full Text] [Related]
16. Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.
Levoye A; Jockers R; Ayoub MA; Delagrange P; Savaskan E; Guillaume JL
Chronobiol Int; 2006; 23(1-2):419-26. PubMed ID: 16687315
[TBL] [Abstract][Full Text] [Related]
17. Melatonin MT
López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of melatonin ligands.
Delagrange P; Boutin JA
Chronobiol Int; 2006; 23(1-2):413-8. PubMed ID: 16687314
[TBL] [Abstract][Full Text] [Related]
19. MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro.
Sampaio RV; Conceição S; Miranda MS; Sampaio Lde F; Ohashi OM
Reprod Biol Endocrinol; 2012 Dec; 10():103. PubMed ID: 23207065
[TBL] [Abstract][Full Text] [Related]
20. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors].
Schuster C
J Soc Biol; 2007; 201(1):85-96. PubMed ID: 17762828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
